|
Clinical Research Conference
The American Federation for Medical Research (AFMR) hosted a high-profile symposium that convened many of our nation’s foremost leaders and influencers in the Health Care sector. This all-day symposium, entitled The Current Crisis in Clinical Research: Where Do We Go?, took place on Tuesday, April 14, 2009 in Washington, D.C. The purpose of the symposium was to generate discussion and action for patient-oriented clinical research in the United States among the constituents who are in the strongest positions to stimulate much-needed change. Without the kind of change these leaders can bring about, the clinical research enterprise in the U.S. will continue to deteriorate, causing irreparable damage to the economy and the quality of medical care patients across the world receive for generations to come. Several panel discussions throughout the day included the following speakers:
-
Fran Drescher, cancer survivor, star of the hit TV series "The Nanny", and founder of Cancer Schmancer, www.cancerschmancer.org
-
Dr. Anthony Hayward, National Center for Research Resources, National Institutes for Health
-
Dr. Lawrence Tabak, Acting Deputy Director of the NIH
-
Dr. Douglas Throckmorton, Deputy Director of the Center for Drug Evaluation and Research of the FDA
-
Dr. Molly Kretsch, Deputy Administrator of the Agricultural Research Service, USDA
-
Ms. Ellen Embrey, Acting Principal Deputy Asst. Secretary of Defense, U.S. Department of Defense
-
Dr. Darrell Kirch, President and CEO of the Association of American Medical Colleges
-
Dr. Barry Gertz, Senior VP for Clinical and Quantitative Science of Merck & Co.
-
Dr. Pamela Davis, Dean of Case Western Reserve University School of Medicine
-
Dr. Samuel Klein, William H. Danforth Professor of Medicine and Nutritional Science at Washington University School of Medicine
-
Dr. Timothy Lipman, Chief, GI-Hepatology-Nutrition Section, Department of Veterans Affairs Medical Center
-
Dr. Kevin Schulman, Professor of Medicine and Business Administration at Duke University Medical Center
-
Dr. Alan Buchman, President of the AFMR and Professor of Medicine and Surgery at Northwestern University
Here is an outline of the schedule:
April 14, 2009 - The Current Crisis in Cinical Research: Where Do We Go?
The Crisis
Welcome and the State of Clinical Research in America
Alan L. Buchman, MD, MSPH, President, American Federation for Medical Research
Professor of Medicine and Surgery, Feinberg School of Medicine, Northwestern University
Putting the Crisis into Perspective - the Investigator
Samuel Klein, MD, William H. Danforth Professor of Medicine and Nutritional Science
Washington University School of Medicine
Putting the Crisis in Perspective - the Patient
Sabine Miller-Patient
Fran Drescher-Hollywood Star
The Loss of Clinical Investigators – A Loss to Society
Darrell Kirch, MD,, President and CEO, Association of American Medical Colleges
The Impact of the Crisis in Clinical Research on New Drug Development
Barry Gertz, MD, PhD, Senior Vice President for Clinical and Quantitative Science
Merck & Co., Inc.
Research and Ethics: The Industrial – Institutional - Investigator Interface
Timothy O. Lipman, MD, Chief, GI-Hepatology-Nutrition Section
Department of Veterans Affairs Medical Center
Professor of Medicine, Georgetown University School of Medicine
The Crisis in Training and Education a Future Generation of Clinical Investigators
Pamela B. Davis, MD, PhD, Dean, Case Western Reserve University School of Medicine
Dollars and Sense: How Clinical Research Adds Up
Kevin A. Schulman, MD, Professor of Medicine and Business Administration
Duke University Medical Center
The Players
The CTSA; What They Are and What They Will Accomplish for Whom
Anthony Hayward, MD, PhD, National Center for Research Resources, NIH
The FDA: Our Role in Clinical Research
Douglas Throckmorton, MD, Deputy Director Center for Drug Evaluation and Research, FDA
The USDA: Our Role in Clinical Research and Commitment to a Healthy Lifestyle
Molly Kretsch, PhD, Deputy Administrator for Nutrition, Food Safety, and Quality, Agricultural Research Service, USDA
The DOD: More Than Just Protecting Our Troops
Ms. Ellen Embrey, Acting Principal Deputy Assistant Secretary of Defense
In a World of GPS, Why a Roadmap and is Translational Research a Two-Way Street?
Lawrence A. Tabak, DDS, PhD, Acting Deputy Director, NIH
Funding Clinical Research and Our National Priorities
Senator Arlen Specter (R-PA)
How can we alter the future?
Sum Up and Priorities for the Future
Alan L. Buchman, MD, MSPH
We are losing clinical investigators in American for several reasons: 1) there are increased pressures in academia to separate those who do research from those who see patients, 2) there is an increased demand of those in academia who see patients to increase clinical revenue and forgo clinical observations that could lead to meaningful research hypotheses, 3) there are fewer clinicians involved in meaningful clinical research, 4) the educational program to train the next generation of clinical investigators is insufficient and under-funded, 5) the infrastructure for clinical research has eroded, and the lack of publicly-supported research databases does not allow easy access of patients to clinical studies, 6) relatively little clinical investigation is funded via public sources, and 7) there are those who think clinical research is the purview of industry.
We are taking the first step in combating the crisis and identifying and enacting solutions.
Sincerely,
Alan L. Buchman, MD, MSPH
President, AFMR
|
